Vtv Therapeutics Is A Clinical Stage Biopharmaceutical Company Founded In 2010The Company Focuses On Developing Innovative Oralsmall Molecule Drug Candidates Aimed At Improving The Lives Of Patients With Diabetes And Other Chronic Conditionsits Leading Product Is Cadisegliatinwhich Is Being Explored As An Adjunctive Therapy To Insulin For Type 1 Diabetesas Well As For Type 2 Diabetes And Other Chronic Conditions The Company Emphasizes Scientific Excellence And Patient Centricityinvesting Significantly In Research And Development To Identify New Therapeutic Targetsvtv Therapeutics Collaborates With Academic Institutionsbiotechnology Companiesand Pharmaceutical Firms To Enhance Its Drug Development Effortsthe Company Has Achieved Important Regulatory Milestonesincluding Fda Approvals And Breakthrough Designations For Its Lead Compoundshighlighting Its Potential Impact On Healthcareadditionallyvtv Therapeutics Has Launched An Initial Public Offering To Support Its Growth And Clinical Advancements
No conferences found for this company.
| Company Name | Vtv Therapeutics Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
